Dallas Burston Ashbourne Limited

This website is for Healthcare Professionals. All information contained herein is factual and in the public domain. Dallas Burston Ashbourne Limited is not permitted to enter into discussions or sales and marketing activities with patients or members of the general public. If for any reason you require information you should consult a healthcare professional.

Welcome to the Dallas Burston Ashbourne Limited website.

This website is your one stop resource for information on the company, the people who work here
and our products.

Please use this resource to obtain product information, view and download associated documents,
obtain standard documents such as Medical Enquiry forms and SmPCs, or to contact us. If you prefer
to speak to someone personally the details are listed in the Contact section. Head Office details are
at the foot of the page.

Dallas Burston Ashbourne Limited was formed in 2008 by a former Northamptonshire General Practitioner Dr Dallas Burston.

The company intends to launch a range of high quality, good value prescription medicines with
improved patient compliance and substantial NHS savings.

We enjoy a wealth of knowledge in the area of prescribing, with an exceptional level of knowledge in
how to leverage licensing opportunities to achieve a win win – a win for the company and also for the NHS.

Dallas Burston Ashbourne Limited’s product, Venlalic® XL Tablets (venlafaxine XL tablets) is available in four dosages:
37.5mg
75mg
150mg
225mg – a unique presentation

Dallas Burston Ashbourne Limited has also launched a Fentanyl patch, Fencino. Further information is available in the Products Section.

Dallas Burston - Chairman

Dallas Burston graduated in medicine from St Bartholomew's Hospital
in the mid seventies before going on to work as a GP in
Northamptonshire.

Dallas has established a number of businesses including Ashbourne
Pharmaceuticals, Bartholomew Rhodes and IXL Pharma Ltd.
As well as acting as the Company Chairman and medical advisor,
Dallas is also responsible for product acquisitions and new business
development.

Duncan Morris - Managing Director

Duncan Morris has over twenty five years experience in the
pharmaceutical and health care industry, starting his career as a
medical representative for Merck in Liverpool before moving on to
be a Regional Manager with Sandoz, the Sales Manager at Stiefel,
and the Managing Director of Lundbeck in the UK.

More recently Duncan ran his own contract sales organisation before
joining Dallas Burston Ashbourne Ltd as Managing Director at its
inception in 2009.

Dallas Burston - Chairman

Duncan Morris - Managing Director

NEWS